2m 2m 2m 2m 2m 2m 2m
ELANC ANIML HLTH (ELAN)
NYSE
$25.16+$0.02 (+0.06%)
Price as of Jul 13, 2026 7:52 PM EDT- $12.4BMarket Cap
- 68.84%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
ELANC ANIML HLTH (ELAN)
$25.16+$0.02 (+0.06%)
ELAN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $25.14 | ||
Change | +$0.32 (+1.29%) | ||
Open | $24.62 | ||
High | $25.27 | ||
Low | $24.51 | ||
Previous Close | $24.82 | ||
Volume | 3,208,929 | ||
30-Day Average Volume | 4,696,378 | ||
1-Week Change | 0.04% | ||
1-Month Change | 4.01% | ||
1-Year Change | 68.84% | ||
3-Year Change | 137.17% | ||
5-Year Change | -26.53% | ||
Fundamentals | |||
Shares Outstanding | 499.4M | ||
Total Assets | $13.2B | ||
Market Cap | $12.4B | ||
Enterprise Value | $16.0B | ||
Period: QTR TTM FY | |||
Revenue | $1.4B | ||
Net Income | $57.0M | ||
Free Cash Flow | -$38.0M | ||
EBIT | $87.0M | ||
EBITDA | $259.0M | ||
Net Working Capital | $1.9B | ||
EPS | $0.11 | ||
Enterprise Value/EBITDA | 62 | ||
Enterprise Value/Revenue | 12 | ||
P/B | 2 | ||
P/E | 226 | ||
PEG | 2 | ||
Price/Free Cash Flow | -326 | ||
Price/Operating Cash Flow | 954 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue